• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hepatotoxicity in HIV Patients, An Observational Study in Patients from Tertiary Care Centre of Western India.

作者信息

Bajpai Smrati, Joshi Kavita

机构信息

Assistant Professor.

Associate Professor, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra.

出版信息

J Assoc Physicians India. 2017 May;65(5):47-49.

PMID:28598048
Abstract

OBJECTIVE

HIV AIDS has currently become a chronic manageable condition with HAART, but with its chronicity and lifelong therapy currently the adverse drug reactions to these drugs are the main concern for any treating physician. Hepatotoxicity is one of the prime concerns of any physician managing HIV patients. We observe a number of patients reporting hepatotoxicity in our cohort and this had great impact on the efficacy and intake of the HAART drugs, this led us to explore this area and to find out the prevalence and etiologies in our cohort.

METHODS

Thus we conducted this observational study to determine the prevalence of hepatotoxicity, the various etiologies for hepatotoxicity and assess HAART as the etiology of hepatotoxicity .The study was conducted in the virology department after obtaining ethics committee approval and incompliance with ICH, GCP guidelines. The study was conducted over a span of 3 months and data was collected and analyzed.

RESULTS

Data of 178 Subjects was considered for evaluation of which 10 were excluded due to incomplete information. 168 patients with hepatotoxicity were assessed in the study, the prevalence of hepatotoxicity in our cohort was around 2.25%. Of the 168 patients 111 were male and 57 were female.52 patients were on Antituberculosis therapy (ATT) and thus 30.95% was the incidence rate of hepatotoxicity due to ATT. 23.80% (40 out of 168) were alcoholic and hence it was the etiological agent. HAART as the etiology was observed in 5 patients,2.97%being the incidence .Hepatitis B as the causative agent for hepatotoxicity was observed in 3.57% patients.

CONCLUSIONS

We thus concluded that ATT and alcoholism are major areas of concern in HIV patients and thus a strict monitoring is warranted while prescribing ATT at the same time deaddiction is equally important. HAART induced hepatotoxicity is observed only in a small section of patients and thus these drugs need not be attributed as culprits blindly and put to disrepute.

摘要

相似文献

1
Hepatotoxicity in HIV Patients, An Observational Study in Patients from Tertiary Care Centre of Western India.
J Assoc Physicians India. 2017 May;65(5):47-49.
2
Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decade.在一家血友病治疗中心随访的十年间,抗逆转录病毒药物对合并先天性凝血障碍的HIV-HCV患者的肝毒性。
Haemophilia. 2006 May;12(3):228-36. doi: 10.1111/j.1365-2516.2006.01211.x.
3
Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study.抗结核治疗致肝毒性的危险因素评估:一项前瞻性研究。
Curr Drug Saf. 2020;15(3):198-204. doi: 10.2174/1574886315666200626164554.
4
Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.肝纤维化对合并感染人类免疫缺陷病毒和丙型肝炎病毒患者高效抗逆转录病毒治疗相关肝毒性的影响。
Clin Infect Dis. 2005 Feb 15;40(4):588-93. doi: 10.1086/427216. Epub 2005 Jan 21.
5
Causes of liver disease and its outcome in HIV-infected individuals.HIV感染者肝病的病因及其预后
Indian J Gastroenterol. 2016 Jul;35(4):310-4. doi: 10.1007/s12664-016-0676-6. Epub 2016 Jul 20.
6
The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.在塞尔维亚接受高效抗逆转录病毒治疗(HAART)的艾滋病毒和丙型肝炎病毒合并感染患者队列中肝炎发作的患病率和风险
Biomed Pharmacother. 2008 Jan;62(1):21-5. doi: 10.1016/j.biopha.2006.12.005. Epub 2006 Dec 26.
7
Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.人类免疫缺陷病毒感染者中的乙型肝炎或丙型肝炎合并感染以及抗结核药物对肝功能的影响。
J Postgrad Med. 2006 Apr-Jun;52(2):92-6.
8
Incidence of hepatotoxicity of highly active antiretroviral therapy in a tertiary health centre in Nigeria.
Niger Postgrad Med J. 2012 Sep;19(3):127-32.
9
Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.丙型肝炎感染对HIV疾病进展及初始抗逆转录病毒治疗早期反应的影响。
AIDS. 2006 May 12;20(8):1171-9. doi: 10.1097/01.aids.0000226958.87471.48.
10
HAART and liver: is it safe?高效抗逆转录病毒治疗与肝脏:它安全吗?
J Infect Dev Ctries. 2014 Nov 13;8(11):1444-50. doi: 10.3855/jidc.5012.